SCHEMBL29545383

CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)[C@@H](C)O

nearest known ligand 0.67

Predicted protein targets (top 15)

	gene	UniProt	supporting neighbours	confidence
▸	MAPK8	P45983	1/20	0.67

▸	MAPK9	P45984	1/20	0.67

▸	MAPK10	P53779	1/20	0.67

▸	NPY2R	P49146	8/20	0.56

▸	NPY4R	P50391	8/20	0.56

▸	NPY5R	Q15761	8/20	0.56

▸	NPY1R	P25929	8/20	0.56

▸	EP300	Q09472	1/20	0.55

▸	HIF1A	Q16665	1/20	0.55

▸	EPHA2	P29317	2/20	0.55

▸	NMUR2	Q9GZQ4	2/20	0.54

▸	NMUR1	Q9HB89	2/20	0.54

▸	RAMP3	O60896	1/20	0.53

▸	CALCR	P30988	1/20	0.53

▸	CXCR4	P61073	1/20	0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30826816	0.95	MAPK8 (0.65)	MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30436596	0.92	MAPK8 (0.65)	MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30607441	0.92	MAPK8 (0.64)	MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL29679864	0.90	MAPK8 (0.62)	MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL31430940	0.90	NPY2R (0.60)	MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30835683	0.90	NPY2R (0.62)	MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30495779	0.89	NPY2R (0.65)	MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30571141	0.89	MAPK8 (0.59)	MAPK8MAPK9MAPK10EPHA2NMUR2
SCHEMBL31743445	0.88	EPHA2 (0.59)	MAPK8MAPK9MAPK10NPY2RNPY4R
SCHEMBL30438334	0.88	MAPK8 (0.61)	MAPK8MAPK9MAPK10NPY2RNPY4R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20220153783-A1	MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES	FUSION BIOTECHNOLOGY CO., LTD. (KR)	2022-05-19	—	—	US	claimed
US-20260097092-A1	PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA-TARGETING COMPOUND AS ACTIVE INGREDIENT FOR TREATING MACULAR DEGENERATION	ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY (KR)	2026-04-09	—	—	US	disclosed
WO-2024063223-A1	PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA-TARGETING COMPOUND AS ACTIVE INGREDIENT FOR TREATING MACULAR DEGENERATION	울산과학기술원	2024-03-28	—	—	WO	disclosed
US-20220153783-A1	MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES	FUSION BIOTECHNOLOGY CO., LTD. (KR)	2022-05-19	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20260097092-A1	PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA-TARGETING COMPOUND AS ACTIVE INGREDIENT FOR TREATING MACULAR DEGENERATION	ARG2, NLN, RHOT2	MAPK8 1052/4885MAPK9 679/4885MAPK10 468/4885
US-20220153783-A1	MITOCHONDRIA-TARGETING COMPOUND AND COMPOSITION COMPRISING SAME FOR TREATING OR PREVENTING AGING-RELATED DISEASES	TFAM, HSPA9, AIFM1	MAPK8 1685/4885MAPK9 1411/4885MAPK10 826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.